A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: Design of the RENEW study-Reference-Cited by-同舟云学术

A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: Design of the RENEW study

Published:2013-06 Issue:6 Volume:165 Page:854-861.e2
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Povsic Thomas J.,Junge Candice,Nada Adel,Schatz Richard A.,Harrington Robert A.,Davidson Charles J.,Fortuin F. David,Kereiakes Dean J.,Mendelsohn Farrell O.,Sherman Warren,Schaer Gary L.,White Christopher J.,Stewart Duncan,Story Kenneth,Losordo Douglas W.,Henry Timothy D.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference24 articles.

1. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease;Serruys;N Engl J Med,2001

2. The problem of chronic refractory angina. Report from the ESC Joint Study Group on the Treatment of Refractory Angina;Mannheimer;Eur Heart J,2002

3. Recommendations for advancing the care of Canadians living with refractory angina pectoris: a Canadian Cardiovascular Society position statement;McGillion;Can J Cardiol,2010

4. Angina patients' ratings of current health and health without angina;Chen;Med Decis Making,1996

5. Fatality, morbidity and quality of life in patients with refractory angina pectoris;Andréll;Int J Cardiol,2011

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advanced cell and gene therapies in cardiology;eBioMedicine;2024-05

2. EXACT Trial: Results of the Phase 1 Dose-Escalation Study;Circulation: Cardiovascular Interventions;2023-08

3. Single cell and lineage tracing studies reveal the impact of CD34+ cells on myocardial fibrosis during heart failure;Stem Cell Research & Therapy;2023-02-20

4. The Long Telling Story of “Endothelial Progenitor Cells”: Where Are We at Now?;Cells;2022-12-28

5. Therapeutic Angiogenesis Using Autologous CD34-Positive Cells for Vascular Diseases;Annals of Vascular Diseases;2022-12-25